Brief: Kineta Presents New Preclinical Data On Lead Anti-Cd27 Agonist Antibody
04/10/2023 13:45
Oct 4 (Reuters) - Kineta Inc KA.O :
* KINETA PRESENTS NEW PRECLINICAL DATA ON LEAD ANTI-CD27
AGONIST
ANTIBODY AT AACR SPECIAL CONFERENCE ON TUMOR IMMUNOLOGY AND
IMMUNOTHERAPY
Source text for Eikon: ID:nGNX1ktHKP
Further company coverage: KA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kineta
See all newsBrief: TuHURA Biosciences And Kineta Stockholders Approve Proposed Merger And All Related Proposals
Brief: Kineta Updates KVA12123 Clinical Results From Ongoing Phase 1/2 Vista101 Study At Society For Immunotherapy Of Cancer
U.S. STOCKS ON THE MOVE-Copper miners, Palo Alto Networks, Lowe's
U.S. STOCKS ON THE MOVE-Lineage, J.B. Hunt, McDonald's
Kineta rises on resuming enrollment in early-stage cancer study